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Abstract Chemical-based risk assessment under-
pins the current approach to responsible development
of nanomaterials (NM). It is now recognised, how-
ever, that this process may take decades, leaving
decision makers with little support in the near term.
Despite this, current and near future research efforts
are largely directed at establishing (eco)toxicological
and exposure data for NM, and comparatively little
research has been undertaken on tools or approaches
that may facilitate near-term decisions, some of
which we briefly outline in this analysis. We propose
a reprioritisation of NM risk research efforts to
redress this imbalance, including the development of
more adaptive risk governance frameworks, alter-
native/complementary tools to risk assessment, and
health and environment surveillance.
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Introduction
While global sales of nanoproducts are expected to
reach € 450 billion within the next year (Hanssen
et al. 2008), scientists and regulators are still left with
many questions as to whether nanomaterials (NM)
pose a risk to human health or the environment. The
risk assessment framework developed for chemicals
remains the predominant decision support tool,
underpinning regulations that cover NM or providing
information to make the case for regulatory amend-
ment (Rocks et al. 2008). This framework is well
known to many, comprising hazard identification,
hazard assessment and risk characterization (includ-
ing considerations of exposure) (Rocks et al. 2008;
EPA 2009; Owen et al. 2009b). Associated uncer-
tainty in the process can be managed, for example by
the application of safety factors (European Commis-
sion 2003; Owen et al. 2009b). While it is recognised
that methodologies underpinning the conceptual risk
assessment frameworks (e.g. EU Technical Guidance
Document (TGD), Organisation for Economic
Co-operation and Development (OECD) Test Guide-
lines) may not be entirely fit for purpose (e.g. Crane
et al. 2008), the general consensus has been that in
principle the chemical risk assessment framework is
sound to use for NM with some modifications
(European Commission 2008b; OECD 2008a; SCEN-
IHR 2007, 2009).
Whereas, in principle, risk assessment is a sound
approach, in practice, it is not an easy task to
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complete as there are some very significant chal-
lenges to first overcome (e.g. Maynard et al. 2006). It
is now acknowledged that its completion will quite
possibly take decades even for those NM that are
currently on the market, let alone those that are
emerging. Similar challenges have been faced for
other chemicals (e.g. endocrine-disrupting chemicals,
Sumpter and Johnson 2008). However, NM may
represent an extreme case due to their diversity (e.g.
particle sizes, functionalities) and range of applica-
tions (Owen and Handy 2007; RCEP 2008; Linkov
et al. 2009a). While the question of identifying the
most appropriate mechanism(s) to support timely
decisions (e.g. interventions) in the face of little or no
data is far from new (Collingridge 1980), it may be
more challenging for NM and, at the same time, of
utmost importance given the ubiquitous nature of
nano-embedded consumer products and applications
(Project on Emerging Nanotechnologies 2008). Some
fundamental questions concerning whether NM risk
research efforts have been directed in the most
effective fields for timely decisions regarding envi-
ronment, health and safety risks include: How do
research efforts compare between the fields dedicated
to using traditional risk assessment frameworks and
alternative or complementary frameworks or tools for
NM? Are programs that feed into chemical-based risk
assessment made at the expense of research into tools
that can support near-term decisions? What are the
alternatives to traditional risk assessment currently
available and what are their strengths and weak-
nesses? This analysis aims to address these critical
questions, in addition to providing a snapshot of
publications, projects and funding schemes made in
these fields. We then propose some recommendations
for future NM risk research schemes to help
ensure the responsible innovation of NM as well as
ultimately protect human and environmental health.
Risk assessment as a decision support tool:
challenges posed by nanomaterials
Scientists, international organizations and regulatory
agencies have been actively working towards devel-
oping risk assessment for NM in recent years (e.g.
NNI 2008b; EPA 2009; OECD 2009d; SCENIHR
2007, 2009). In general, it has not yet been possible to
complete individual NM risk assessments (SCENIHR
2009) due to extensive uncertainties and knowledge
gaps within nearly all aspects of the risk assessment
process (RCEP 2008; Grieger et al. 2009). Among
other challenges, there is a distinct lack of quantita-
tive exposure and hazard data for both humans and
environmental species for many NM (Crane et al.
2008; Handy et al. 2008; SCENIHR 2009; Wiesner
et al. 2009). In addition, a number of key methodolog-
ical concerns have been raised, including uncertainty
in applying standardized test methods developed for
chemicals to NM (e.g. to quantify hazards including
sample preparation for (eco)toxicity studies, charac-
terisation of NM in test systems, dosimetry and
reporting metrics) (Crane et al. 2008; Powell et al.
2008; Shatkin 2008). Furthermore, there are also
difficulties in detecting and quantifying NM in com-
plex environmental matrices (Owen and Handy 2007;
Hassellov et al. 2008).
Based upon a reflection of these challenges and in
response to calls for more research (e.g. Maynard
et al. 2006), increased efforts regarding these have
been underway. For example, scientists and organi-
sations have been actively generating and analysing
data for effects and exposure assessments as well as
reviewing risk assessment methodologies for their
appropriateness for NM. Academics and scientists in
government and regulatory agencies all play a role in
these developments, as well as industry, for example
under chemicals legislation in relation to NM (e.g.
Registration, Evaluation, Authorisation and Restric-
tion of Chemical substances, REACH) (European
Commission 2008b).
In the EU, the European Commission’s Scientific
Committee on Emerging and Newly Identified Health
Risks (SCENIHR) has recently reviewed the avail-
able data for risk assessment of NM (SCENIHR
2009). They conclude that the risk assessment
framework seems applicable to NM although they
acknowledge and describe many of its limitations,
stating that the risk assessment process is still under
development. Others such as the European Food
Safety Authority have recently published similar
conclusions, stating that although there are some
major (e.g. methodological) challenges, current risk
assessment methodologies are expected to be appli-
cable for NM in food and feed applications in
principle, and assessments should be undertaken on a
case-by-case basis (European Food Safety Authority
2009).
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The challenges for risk assessment posed by NM
are reflected by a significant program of work at the
Organisation for Economic Co-operation and Devel-
opment’s working party on (manufactured) NM
(WPMN). An array of projects are being directed,
including the development of a NM risk research
database (OECD 2009d), analysis of test methods
(which underpin chemicals risk assessment) as
applied to NM and a sponsorship program that will
acquire risk assessment data for 14 NM of current
relevance (OECD 2008b). Further study has also been
undertaken to prioritize research needs to close the
known knowledge gaps as quickly as possible,
supporting the performance of risk assessments often
in the context of current regulatory testing require-
ments (DEFRA 2006, 2007; Maynard et al. 2006;
ICON 2008; NNI 2008b; Elder et al. 2009; SCENIHR
2009).
On the whole, a consensus is beginning to emerge:
risk assessment frameworks for chemicals should be
appropriate for NM, but they most likely need some
methodological modifications. Exactly what modifi-
cations are needed is not consistently made clear, and
how long it will take to make these modifications is
also not often stated.
Despite these serious technical challenges that risk
assessors face, most knowledge gaps are expected to be
reduced in due course because of their epistemic nature
(RCEP 2008; Grieger et al. 2009). It is anticipated that
eventually standardized testing methodologies and
analytical tools will be developed alongside full NM
characterization and dose–response data (ISO 2008a, b;
OECD 2008a, b). History has shown many examples in
which regulatory test methods were developed and
applied (Baun and Hansen 2008; OECD 2009a, b) in
response to new knowledge (e.g. endocrine-disrupting
chemicals, Sumpter and Johnson 2008), and later test
methods were developed (OECD 2009a, b). In fact, a
recent review of the applicability of OECD test
guidelines for NM (OECD 2009e) shows this process
in action: some test guidelines for NM physical
chemical properties appear to be adequate for NM
(e.g. TG 102, 109, 113, 116), some may be applicable
in some cases or for some NM (e.g. TG 101, 105, 106,
etc.), while other guidelines are considered inadequate
(e.g. TG 103, 114).
However, how long will this process take espe-
cially given the diversity of NM and applications?
A recent analysis estimates that testing existing
nanoparticles in the USA alone will cost between
$249 million and $1.18 billion and take 34–53 years
for completion (Choi et al. 2009). Earlier analyses
also estimated, at least, a decade for the acquisition of
some critical knowledge within the field (Maynard
et al. 2006). Given this, some have suggested that
more rapidly deployable decision-support frameworks
and/or tools need to be applied now (Hansen 2009;
Linkov et al. 2007, 2009a; Mantovani et al. 2009;
Metcalfe et al. 2009). In addition, others have
proposed the need for risk governance1 mechanisms
that can be enacted far earlier in the nano-innovation
process, reducing the time needed to acquire critical
risk characterisation data (Lee and Jose 2008; Owen
et al. 2009a). In some cases, the precautionary
principle2 has been invoked to support decisions in
the absence of full scientific certainty. For instance,
the Environment Agency in the UK recommended
that unbound carbon nanotubes are treated as haz-
ardous waste (Environment Agency 2008). Others,
however, have concluded that, for the most part, there
is still insufficient evidence to invoke the precaution-
ary principle (Aitken et al. 2009; Stebbing 2009),
and, hence, this issue may quite possibly take many
years to resolve.
Current and near-future research effort
distributions
In order to gauge whether current NM risk research
efforts are responding to the challenges outlined
above, we have undertaken a snapshot review of
research efforts, mainly in terms of peer-reviewed
journal publications, research projects and public
funding within the fields of traditional risk assess-
ment paradigms, complementary tools to risk assess-
ment and risk governance mechanisms as they apply
to NM. This is not intended to be a complete analysis
of research publications and projects within the field
of environment, health and safety aspects (EHS) of
NM (see e.g. Aguar and Murcia Nicola´s 2008;
1 Defined according to Renn (2008): ‘‘Risk governance
includes the totality of actors, rules, conventions, processes
and mechanisms concerned with how relevant risk information
is collected, analysed and communicated, and how manage-
ment decisions are taken’’.
2 As described by the European Commission (2000).
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SCENIHR 2009 for more complete overviews);
instead, we aim to provide a synopsis of the general
direction and distribution of efforts to date.
We searched peer-reviewed journal articles within
different nano-risk-related fields using the ISI Web of
Knowledge article database (http://apps.isiknowledge.
com) and the International Council on Nanotechnology
(ICON) database (‘quick’ and ‘advanced’ searches,
http://icon.rice.edu/research.cfm) which specifically
focuses on EHS issues of NM. In addition, the OECD
research project database (http://webnet.oecd.org/
NanoMaterials/Pagelet/Front/Default.aspx?) which
also specifically focuses on projects within health and
environmental safety of NM was also searched. These
databases were accessed and used on 30 June 2009. See
Fig. 1 for more details on the search methodology,
including search terms used.
In terms of the number of published research articles
and research projects within different nano-risk
fields, the majority (60.1%) of these research efforts
were within the topics of ‘toxicity, ‘ecotoxicity’ and
‘exposure’ of NM (Fig. 1). There were also relatively
high numbers of research articles found in topics of
‘management’ and ‘monitoring’ of nanotechnology,
-material or -particle using the ISI Web of Knowledge,
although the number of articles found within these
topics is significantly less when using the ICON
database which specifically focuses on EHS aspects of
NM. In comparison, only 6.8 and 1.6% of research
efforts were in the areas of ‘risk governance’ and
‘decision making’, respectively.
Similar patterns are also seen in the distribution of
research projects completed or underway within NM
EHS issues. According to the OECD project database
for health and environmental safety research of
NM, there were 153 projects listed under topics of
‘exposure’ and 99 projects within ‘toxicity’ or ‘eco-
toxicity’, compared to 45 within ‘risk assessment’,
37 within ‘monitoring’, 16 within ‘management’ and 6
within ‘risk management’. Only two projects are
within the field of ‘risk governance’ and three in the
field of ‘decision making’ (Fig. 1).
Fig. 1 Comparison of number of journal article publications
and research projects within different nano-risk topics and
environment, health and safety (EHS) issues of nanomaterials
(NM). The ISI Web of Knowledge (http://apps.isiknowledge.
com) and ICON Virtual Journal (http://icon.rice.edu/research.
cfm) which specifically focuses on EHS issues of NM (using
both ‘quick’ and ‘advanced’ search options) were used to
search for scientific journal publications. The OECD NM
risk research project database (http://webnet.oecd.org/Nano
Materials/Pagelet/Front/Default.aspx?) was used to search
for completed or on-going research projects, shown on the
secondary axis. Searches were made within all years in these
databases, and were accessed and used on 30 June 2009. The
following search terms were used within the ‘topic’ fields
of the database search engines: ‘toxicity’, ‘ecotoxicity’,
‘exposure’, ‘risk assessment’, ‘risk management’, ‘risk gover-
nance’, ‘decision making’, ‘management’ and ‘monitoring’.
Since the ISI Web of Knowledge database is not confined to
NM risk research, as in the case of the ICON and OECD
databases, the previously cited search terms were used together
with ‘nanotechnology’, ‘nanomaterial’ or ‘nanoparticle’
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It is evident, not unsurprisingly, that much of the
ongoing research fits within a chemical-based risk
assessment paradigm. Very little research is directly
addressing the key issues of near-term decision
support highlighted above and by others (RCEP
2008; Brown 2009; Linkov et al. 2009b).
Furthermore, this situation is not likely to change
in the near future. Of the nearly 200 projects funded
either through the EU Framework Programmes
(totally € 32 million), EU Member States, Candidate
Countries or Countries associated to Sixth Frame-
work Programme (FP6) or Seventh Framework
Programme (FP7) (totally € 47 million), only a few
projects focus on risk governance or decision making
(Aguar and Murcia Nicola´s 2008). The great majority
of projects have been dedicated towards improving
technical knowledge or developing new test protocols
and equipment. Similar patterns are seen in US public
funding schemes through the National Nanotechnol-
ogy Initiative (NNI 2008a, b). Funding schemes
outlined by the EU’s current FP7 programme do not
appear to deviate much from previous research prior-
ities (Aguar and Murcia Nicola´s 2008; European
Commission 2009). The recent FP7 call, (Theme 4
Nanosciences, Nanotechnologies, Materials and New
Production Technologies—NMP), published 29 July
2009, is aimed largely at gaining more technical
knowledge for risk assessment (European Commission
2009). Very few references are made on improved
governance or decision making of nanotechnologies,
with no specific calls within these areas. These are
largely subsumed within wider goals, such as improved
social acceptance, sustainable development and the
development of reference materials. This is not
surprising given the overarching strategy outlined by
the EU nanotechnologies action plan (European Com-
mission 2005) which is yet to acknowledge the key
issues raised in this article and by others (e.g. RCEP
2008).
Redressing the imbalance: a path forward
and recommendations
This analysis has shown that despite the recognized
serious challenges that NM present for fulfilling
traditional chemical-based risk assessment frame-
works and the time this will likely take, the large
majority of decision support research is directed to fit
ultimately within this framework. Decision makers,
therefore, may not be well equipped to make
decisions concerning NM under conditions of exten-
sive uncertainty in relation to environmental and
human health protection in the near term. It is clear,
in our view, that there is a need for a program of
research and knowledge transfer specifically aimed at
supporting near- and medium-term decision making,
in real time and at the same pace as nano-innovation
Box 1 In response to the challenges of potential health and
environmental risk assessments of nanomaterials (NM) and
making decisions regarding these potential risks, as highlighted
in this analysis, we propose some key areas for future research
to ensure the responsible emergence of nanotechnologies
Recommendation Rationale Implementation
Adaptive and more
responsive risk
governance frameworks
Rapid nanotechnologies innovation
out-paces regulatory governance based
on traditional risk assessment
Encourage and support research on risk governance
which specifically focuses on timely yet informed
decision making in light of uncertainty and rapid
nano-innovationLengthy, post-innovation risk
investigations Integrate responsible innovation early (upstream)
in innovation process
Alternative, complementary
tools to risk assessment
Early approximate risk evaluations Immediate, rigorous testing of already-developed
tools to fully evaluate their functionality and
limitations
Relative comparison of NM risks for
decision support
Continue development of new tools including those
which may complement risk assessment
Health and environmental
surveillance
Early warning system Use of biomonitoring, such as:
Potential safety net Filter-feeders in aquatic ‘hot spots’
Monitor health of occupational workers
Direct Toxicity Assessment of effluents
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itself (Guston and Sarewitz 2002), see Box 1.
Furthermore, since there are already a number of
NM on the market with varying degrees of potential
for exposure (Limbach et al. 2008; RCEP 2008;
SCENIHR 2009), we also recommend the use of
environment and health surveillance as an early
warning system to act as a safety net around such a
decision support program, to which it may also serve
to inform (Box 1). We have highlighted these areas
that might be worthy of consideration in such a
research program in Box 1 and provide further
justification for these in the following section.
Adaptive and more responsive risk governance
frameworks
If the development of regulation based on quantitative
risk assessment is an inherently slow governance
process, then one answer might be to undertake
research that leads to one or more governance frame-
works that are more responsive and adaptive. This is a
view that has been articulated by a number of authors,
including RCEP (2008), Brown (2009) and Owen et al.
(2009a). There is a foundation for this study, including
a number of alternative risk governance frameworks
that have been proposed in recent years, such as those
suggested by the International Risk Governance
Council (IRGC 2007), Environmental Defense and
Dupont (Nano Risk Framework, Environmental
Defense and Dupont 2007) and SMARTEN (Strategic
Management and Assessment of Risks and Toxicity of
Engineered Nanomaterials) (Metcalfe et al. 2009).
These typically not only combine some of the
traditional parameters of risk assessment (hazard
identification, exposure assessment, etc.) and risk
management (in the case of the Nano Risk Frame-
work), but may also incorporate wider aspects (e.g.
social, economic and cultural aspects, expert analysis).
Others have proposed broader governance models
for decision making of nanotechnology. For example,
real-time technology assessment attempts to integrate
nano-science and innovation with social science and
policy at early stages of research and development
rather than dealing with decision-making issues after
innovation has already taken a place in society
(Guston and Sarewitz 2002). This has the potential
to prevent lengthy post-NM production debates
by addressing key issues early in the innovation
process, given that the inclusive steps involved are
coordinated and well guided to minimize delay in
the process. While real-time technology assessment
mainly aims to assist decision-making processes by
incorporating other (societal) factors, it is not yet
clear if more timely decisions will ultimately be aided
by this process.
Others have specifically recognised the key issue
of driving governance ‘upstream’ in the nano-inno-
vation process. For example, the European Commis-
sion’s Code of Conduct for Nanosciences and
Nanotechnologies Research was established in 2007
(European Commission 2008a), providing guidance
to steer the responsible development of nanotechnol-
ogy at an early stage. This includes specific recom-
mendations aimed towards enhancing communication
of the risks, benefits and uncertainties in addition to
the development of scientific tools and knowledge,
albeit described, in general, rather than in specific
terms.
In short, while there are a number of potential
avenues to pursue, a comprehensive programme of
research in this area is currently lacking. Therefore,
we recommend the continued development of
research on risk governance frameworks that specif-
ically aims to strengthen the timeliness of decision
making processes in the face of rapid nanotechnol-
ogies innovation.
Alternative, complementary tools to risk
assessment
In addition to the risk governance frameworks and
approaches described above, a wide variety of tools
have either been developed or deployed for approx-
imate risk evaluations or decision making about
(some) NM risks using available information.
These include the Precautionary Matrix to identify
potentially dangerous applications within production
(Ho¨ck et al. 2008) and a categorisation framework to
identify different exposure potentials based on the
location of the nano-structured material in a product
(Hansen et al. 2008). Multi-Criteria Decision Anal-
ysis (MCDA) and SMAA–TRI models have also been
proposed, which compare and rank alternatives in
NM risk decision making (Linkov et al. 2007;
Tervonen et al. 2009). Furthermore, expert elicitation
has been put forth to help compensate for large data
gaps (Morgan 2005), as well as adaptive management
to help create flexible and iterative processes (Davis
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2007; Linkov et al. 2007). In general, these tools
attempt to provide either an early attempt to approx-
imate or compare some NM risks for decision
support, even if it is, for example ranking the risks
of different nanoparticles.
While these tools and models may be valuable in
many aspects, especially in terms of ‘thinking outside
the box’ in regard to early estimates and comparisons
of NM risks and better decision-making strategies, one
main limitation is that many (if not most) of these tools
and models have not been thoroughly ‘tested’ and
applied to many NM, and, therefore, their robustness
and applicability is not yet clear. Therefore, we
recommend that the developed frameworks and tools,
some of which have been described here, be immedi-
ately and rigorously tested to fully evaluate their
functionality and limitations. This should be comple-
mentary to the continued development and amendment
of alternative governance frameworks and tools.
The need for surveillance
Since decisions under uncertainty and especially
ignorance will always be prone to varying degrees
of error, some have suggested the need for ‘corrigi-
bility’ (Collingridge 1980). In other words, under
uncertain circumstances, it is important to ensure that
such decisions can be reversed at minimum cost
(economic or otherwise). Hence, environmental and
health surveillance may have the potential to serve as
an important safety net or early warning system
(Owen et al. 2009b; Saunders and Mohammed 2009;
Schulte et al. 2009) to any decision support system
for NM risks, whether based on prospective risk
assessment or an alternate framework. In particular,
the use of biomonitoring may be particularly useful
given the difficulties in detecting and measuring
nanoparticles in complex environmental matrices
(e.g. Hassellov et al. 2008). This might include
evaluating the toxicity of NM-containing environ-
mental discharges (e.g. ‘whole effluent assessment’
or ‘direct toxicity assessment’, Owen et al. 2009b) or
the use of filter feeding organisms in aquatic envi-
ronments where there is an anticipated high degree of
exposure to NM (Baun et al. 2009). Biomonitoring
may also encompass the monitoring and surveillance
of occupational workers’ health in the light of
potentially hazardous effects of NM (Nasterlack
et al. 2008). In fact, the National Institute of
Occupational Health and Safety (NIOSH) recently
recommended hazard surveillance as a foundation to
implement safety measures (NIOSH 2009), and the
OECD has recommended the inclusion of health
monitoring, surveillance and biological monitoring
for occupational workers (OECD 2009c).
Conclusions
Although the traditional chemical-based risk assess-
ment framework is a powerful approach, its use for
estimating the health and environmental risks of NM
in the near-term may be limited due to the time and
costs needed to generate meaningful results. This is
due to the extensive risk uncertainties and complex
types and numbers of NM encountered in current
production. The fast-paced development of NM and
nanoproducts is only compounding this problem.
Given these limitations, decision makers may not
currently be well equipped if decisions are to be
based mainly upon results generated from quantita-
tive risk assessment. We see this as the central issue
for the responsible emergence of nanotechnologies.
Despite the above, research efforts thus far have
been mainly put towards acquiring knowledge that
will most likely be fed into chemical-based risk
assessment procedures. These efforts include a pre-
dominance of research publications and projects
within the fields of (eco)toxicology and human and
environmental exposure of NM, while research in
broader issues such as decision making and risk
governance are comparatively minimal. Research
supporting quantitative risk characterization of NM
is indeed important, and we do not advocate aban-
donment of this at any cost. However, as scientists
and policy makers, we must face the reality that
knowledge gaps are not expected to be closed in the
near future and may take decades to close in many
cases. In order to ensure the protection of the
environment and human health, this suggests the
need for a research programme as significant as that
which feeds into quantitative risk assessment and
which addresses the fundamental issue of timely, yet,
informed decision making regarding potential NM
risks. Although a few alternative risk frameworks
have been proposed, it is not clear whether they will
address this key concern. Furthermore, although
some complementary governance approaches and
J Nanopart Res (2010) 12:383–392 389
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decision support tools have been suggested, their
comprehensive evaluation and development has yet
to be undertaken.
In conclusion, we suggest the need for an interna-
tional research programme that specifically addresses
critical issues of risk governance and timely deci-
sion making as these relate to NM specifically, and
emerging technologies more generally. This pro-
gramme might include research into more efficient
and anticipatory risk governance mechanisms as well
as a systematic evaluation of available complementary
tools to risk assessment and, where necessary, further
tools under development. Finally, the development of
environmental and health surveillance is needed to act
as a safety net and an early warning system while these
issues are being addressed. We recommend that active
research within these areas should be among the
essential steps taken in the near future to ensure
the responsible emergence of nanotechnologies, and
ultimately the protection of human and environmental
health.
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